Memantine Protects Rats Treated with Intrathecal Methotrexate from Developing Spatial Memory Deficits
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Purpose: To test whether memantine can prevent methotrexate-induced cognitive deficits in a preclinical model. Experimental Design: After noting that methotrexate exposure induces prolonged elevations of the glutamate analog homocysteic acid (HCA) within cerebrospinal fluid, we tested whether intrathecal injection of HCA would produce memory deficits similar to those observed after intrathecal methotrexate. We then tested whether memantine, an antagonist of the N-methyl-d-aspartate (NMDA) subclass of glutamate receptors, could protect animals treated with clinically relevant doses of intrathecal methotrexate against developing memory deficits. Finally, we asked whether memantine affected this pathway beyond inhibiting the NMDA receptor by altering expression of the NMDA receptor or affecting concentrations of HCA or glutamate within the central nervous system. Results: Four intrathecal doses of methotrexate induced deficits in spatial memory, persisting at least one month following the final injection. Intrathecal HCA was sufficient to reproduce this deficit. Concurrent administration of memantine during the period of methotrexate exposure was protective, decreasing the incidence of methotrexate-induced spatial memory deficits from 56% to 20% (P < 0.05). Memantine neither altered expression of NMDA receptors within the hippocampus nor blunted the methotrexate-induced increases in glutamate or HCA. Conclusions: Excitotoxic glutamate analogs including HCA contribute to cognitive deficits observed after intrathecal methotrexate. Memantine, an NMDA receptor antagonist, reduces the incidence of cognitive deficits in rats treated with intrathecal methotrexate, and may therefore benefit patients with cancer receiving similar treatment. Clin Cancer Res; 19(16); 4446–54. ©2013 AACR.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tonkiss, J., Shultz, P., & Galler, J. R. (1992) · Developmental Psychobiology · doi:10.1002/dev.420250804 · Cited by 71 · cited 1×
“Long Evans rats exhibit high general activity levels, high visual acuity, high levels of exploratory behavior, and robust circadian function (20, 21), leading to more consistent and reproducible behavior on cognitive testing than has been observed in other strains such as Sprague Dawley (22-24).”
Cited by
Wefel, J. S., Kesler, S. R., Noll, K. R., & Schagen, S. B. (2015) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21258 · Cited by 532
Pereira Dias, G., Hollywood, R., Bevilaqua, M. C. D. N., da Silveira da Luz, A. C. D., Hindges, R., Nardi, A. E., & Thuret, S. (2014) · Neuro-Oncology · doi:10.1093/neuonc/not321 · Cited by 85
Haller, O. J., Semendric, I., George, R. P., Collins-Praino, L. E., & Whittaker, A. L. (2023) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2023.105120 · Cited by 13
“Both studies investigated the use of two different chemotherapeutic agents, which were MTX (Cole et al., 2013) and PTX (Sung et al., 2021).”
BackgroundInfluentialKuil, L. E., Varkevisser, T. M. C. K., Huisman, M. H., Jansen, M., Bunt, J., Compter, A., Ket, H., Schagen, S. B., Meeteren, A. Y. N. S.-V., & Partanen, M. (2024) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2023.105514 · Cited by 4
“While promising, the specific mechanism of action for these interventions was not assessed in the included studies. o f Donepezil showed promise in protection from chemotherapy induced cognitive impairment (specifically measured with the Morris water maze) when initiated during chemotherapy 66-69 .”
Metadata
- Authors
- Cole, P. D., Vijayanathan, V., Ali, N. F., Wagshul, M. E., Tanenbaum, E. J., Price, J., Dalal, V., & Gulinello, M. E.
- Venue
- Clinical Cancer Research
- Published
- 2013-08-13
- Volume
- 19
- Issue
- 16
- Pages
- 4446-4454
- ISSN
- 1078-0432 (ISSN-L)
- 1557-3265
- OpenAlex
- W2152255799
- Cited by
- 53
- References
- 1
- FWCI
- 3.41
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Memantine Protects Rats Treated with Intrathecal Methotrexate from Developing Spatial Memory Deficits. https://app.cochat.ai/papers/10.1158/1078-0432.ccr-13-1179
- The paper
- Cole, P. D., Vijayanathan, V., Ali, N. F., Wagshul, M. E., Tanenbaum, E. J., Price, J., Dalal, V., & Gulinello, M. E. (2013). Memantine Protects Rats Treated with Intrathecal Methotrexate from Developing Spatial Memory Deficits. Clinical Cancer Research. https://doi.org/10.1158/1078-0432.ccr-13-1179
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.